Extracorporeal photochemotherapy for treatment of clonal T cell proliferations;La photochimiothérapie extracorporelle dans le traitement de pathologies du système lymphocytaire T

Bulletin du Cancer

Volumn 90, Issue 8-9, 2003, Pages 763-770

  Plumas, Joël ^a   Drillat, Philippe ^a   Jacob, Marie Christine ^a   Richard, Marie Jeanne ^b   Favrot, Marie Christine ^b  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b CHU La Tronche and University   (France)

Author keywords

Clonal T cell proliferation; Extracorporeal photochimiotherapy; Graft versus host disease; Sezary; Transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; AUTOIMMUNE DISEASE; CANCER PATIENT; CELL CLONE; CELL CLONING; CELL PROLIFERATION; CELL SEPARATION; CLINICAL STUDY; CYTAPHERESIS; EXPERIMENTATION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; MONONUCLEAR CELL; ORGAN TRANSPLANTATION; PATHOLOGY; PHOTOCHEMOTHERAPY; SEZARY SYNDROME; T CELL LYMPHOMA; T LYMPHOCYTE; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

AUTOIMMUNE DISEASES; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; PHOTOPHERESIS; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 0141956534     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med 1987; 316: 297-303.
2. Andreu G, Leon A, Heshmati F, Tod M, Menkes CJ, Baudelot J, et al. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. Transfus Sci 1994; 15: 443-54.
3. Barr ML, Meiser BM, Eisen HJ, Roberts RF, Livi U, Dall'Amico R, et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998; 339: 1744-51.
4. Jacob M, Manches O, Drillat P, Richard M, Plumas J, Chaperot L, et al. Quality control for the validation of extracorporeal photopheresis (ECP) process using the Vilbert-Lourmat UV-A irradiation's system. Trans Sci Apheresis (in press).
5. Aubin F, Salard D, Pouthier F, Hervé P, Humbert P. La photochimiothérapie extracorporelle. Médecine/Sciences 1999; 15: 983-9.
6. Duvic M, Hester JP, Lemak NA. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996; 35: 573-9.
7. Gottlieb SL, Wolfe JT, Fox FE, DeNardo BJ, Macey WH, Bromley PG, et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol 1996; 35: 946-57.
8. Prinz B, Behrens W, Holzle E, Plewig G. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: the Dusseldorf and Munich experience. Arch Dermatol Res 1995; 287: 621-6.
9. Zic JA, Stricklin GP, Greer JP, Kinney MC, Shyr Y, Wilson DC, et al. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. J Am Acad Dermatol 1996; 35: 935-45.
10. Jiang SB, Dietz SB, Kim M, Lim HW. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience. Photodermatol Photoimmunol Photomed 1999; 15: 161-5.
11. Bisaccia E, Gonzalez J, Palangio M, Schwartz J, Klainer AS. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. J Am Acad Dermatol 2000; 43: 263-71.
12. Wollina U, Liebold K, Kaatz M, Looks A, Stuhlert A, Lange D. Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemotherapy. Oncol Rep 2000; 7: 1197-201.
13. Fraser Andrews E, Seed P, Whittaker S, Russell Jones R. Extracorporeal photopheresis in Sezary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone. Arch Dermatol 1998; 134: 1001-5.
14. Evans AV, Wood BP, Scarisbrick JJ, Fraser-Andrews EA, Chinn S, Dean A, et al. Extracorporeal photopheresis in Sezary syndrome: hematologic parameters as predictors of response. Blood 2001; 98: 1298-301.
15. Pepino P, Berger CL, Fuzesi L, Panza A, Pierson RN, Gutierrez C, et al. Primate cardiac allo- and xenotransplantation: modulation of the immune response with photochemotherapy. Eur Surg Res 1989; 21: 105-13.
16. Berger CL. Experimental murine and primate models for dissection of the immunosuppressive potential of photochemotherapy in autoimmune disease and transplantation. Yale J Biol Med 1989; 62: 611-20.
17. Horvath KA, Granstein RD. PUVA augments cyclosporine A-mediated rat cardiac allograft survival. J Surg Res 1992; 52: 565-70.
18. Granstein RD, Smith L, Parrish JA. Prolongation of murine skin allograft survival by the systemic effects of 8-methoxypsoralen and long-wave ultraviolet radiation (PUVA). J Invest Dermatol 1987; 88: 424-9.
19. Perez MI, Berger CL, Yamane Y, John L, Latoche L, Edelson RL. Inhibition of anti-skin allograft immunity induced by infusions with photoinactivated effector T lymphocytes: the congenic model. Transplantation 1991; 51: 1283-9.
20. Perez MI, Edelson RL, John L, Laroche L, Berger CL. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Yale J Biol Med 1989; 62: 595-609.
21. Ullrich SE. Photoinacrivation of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versus-host disease across major histocompatibility barriers. J Invest Dermatol 1991; 96: 303-8.
22. Girardi M, McNiff JM, Heald PW. Extracorporeal photochemotherapy in human and murine graft-versus-host disease. J Dermatol Sci 1999; 19: 106-13.
23. Barr ML. Photopheresis in transplantation: future research and directions. Transplant Proc 1998; 30: 2248-50.
24. Costanzo Nordin MR, McManus BM, Wilson JE, O'Sullivan EJ, Hubbell EA, Robinson JA. Efficacy of photopheresis in the rescue therapy of acute cellular rejection in human heart allografts: a preliminary clinical and immunopathologic report. Transplant Proc 1993; 25: 881-3.
25. Heshmati F, Tavakoli R, Michel A, Achkar A, Guillemain R, Couetil JP, et al. Extracorporeal photochemotherapy: a treatment for organ graft rejection. Ther Apher 1997; 1: 121-5.
26. Rose EA, Barr ML, Xu H, Pepino P, Murphy MP, McGovern MA, et al. Photochemotherapy in human heart transplant recipients at high risk for fatal rejection. J Heart Lung Transplant 1992; 11: 746-50.
27. Wieland M, Thiede VL, Strauss RG, Piette WW, Kapelanski DP, Landas SK, et al. Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapy. J Clin Apheresis 1994; 9: 171-5.
28. Andreu G, Achkar A, Couetil JP, Guillemain R, Heshmati F, Amrein C, et al. Extracorporeal photochemotherapy treatment for acute lung rejection episode. J Heart Lung Transplant 1995; 14: 793-6.
29. Salerno CT, Park SJ, Kreykes NS, Kulick DM, Savik K, Hertz MI, et al. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg 1999; 117: 1063-9.
30. Slovis BS, Loyd JE, King LE Jr. Photopheresis for chronic rejection of lung allografts. N Engl J Med 1995; 332: 962.
31. Baron C, Norol F, Dahmane D, Desvaux D, Chopin D, Weil B, et al. Photochemotherapy in kidney transplantation: preliminary results. Transplant Proc 1996; 28: 2823.
32. Dall'Amico R, Murer L, Montini G, Andreetta B, Zanon GF, Zacchello G, et al. Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol 1998; 9: 121-7.
33. Wolfe JT, Tomaszewski JE, Grossman RA, Gottlieb SL, Naji A, Brayman KL, et al. Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature. J Clin Apheresis 1996; 11: 36-41.
34. Child FJ, Ramavel R, Watkins P, Samson D, Apperley J, Ball J, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1999; 23: 881-7.
35. Richter HI, Stege H, Ruzicka T, Soehngen D, Heyll A, Krutmann J. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease. J Am Acad Dermatol 1997; 36: 787-9.
36. Rossetti F, Dall'Amico R, Crovetti G, Messina C, Montini G, Dini G, et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996; 18 (suppl. 2): 175-81.
37. O'Hagan AR, Stillwell PC, Arroliga A, Koo A. Phoropheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation. Chest 1999; 115: 1459-62.
38. Villanueva J, Bhorade SM, Robinson JA, Husain AN, Garrity ER. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant 2000; 5: 44-7.
39. Owsianowski M, Gollnick H, Siegett W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994; 14: 845-8.
40. Dall'Amico R, Messina C. Extracorporeal photochemotherapy for the traitment of graft-versus-host disease. Ther Apher 2002; 6: 296-304.
41. Greinix HT, Volc Platzer B, Rabitsch W, Gmeinhart B, Guevara Pineda C, Kalhs P, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998; 92: 3098-104.
42. Halle P, Paillard C, D'Incan M, Bordigoni P, Piguet C, De Lumley L, et al. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients. J Hematother Stem Cell Ress 2002; 11: 501-12.
43. Greinix HT, Volc-Platzer B, Kalhs P, Fischer G, Rosenmayr A, Keil F, et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 2000; 96: 2426-31.
44. Salvaneschi L, Perotti C, Zecca M, Bernuzzi S, Viarengo G, Giotgiani G, et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001; 41: 1299-305.
45. Alcindot T, Gorgun G, Miller KB, Roberts TF, Sprague K, Schenkein DP, et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001; 98: 1622-5.
46. Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy: results of a multicenter trial. Arch Dermatol 1992; 128: 337-46.
47. Zachariae H, Bjerring P, Heickendorff L, Moller B, Wallevik K, Angelo H. Photopheresis in systemic sclerosis: clinical and serological studies using markers of collagen metabolism. Acta Dermatol Venereol 1993; 73: 356-61.
48. Besnier DP, Chabannes D, Mussini JM, Dupas B, Esnault VL. Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study. Photodermatol Photoimmunol Photomed 2002; 18: 36-41.
49. Rostami AM, Sater RA, Bird SJ, Galetta S, Farber RE, Kamoun M, et al. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis. Mult Scler 1999; 5: 198-203.
50. French LE, Lessin SR, Addya K, Denardo B, Margolis DJ, Leonard DG, et al. Identification of clonal T cells in the blood of patients with systemic sclerosis: positive correlation with response to photopheresis. Arch Dermatol 2001; 137: 1309-13.
51. Krasagakis K, Dippel E, Ramaker J, Owsianowski M, Orfanos CE. Management of severe scleroderma with long-term extracorporeal photopheresis. Dermatology 1998; 196: 309-15.
52. Rook AH. Photopheresis in the treatment of autoimmune disease: experience with pemphigus vulgaris and systemic sclerosis. Ann N Y Acad Sci 1991; 636: 209-16.
53. Wollina U, Lange D, Looks A. Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases. Dermatology 1999; 198: 140-4.
54. Knobler RM, Graninger W, Lindmaier A, Trautinger F. Photopheresis for the treatment of lupus erythematosus: preliminary observations. Ann NY Acad Sci 1991; 636: 340-56.
55. Krasagakis K, Zouboulis CC, Owsianowski M, Ramaker J, Trautmann C, Tebbe B, et al. Remission of scleromyxoedema following treatment with extracorporeal photopheresis. Br J Dermatol 1996; 135: 463-6.
56. Malawista SE, Trock DH, Edelson RL. Treatment of rheumatoid arthritis by extracorporeal photochemotherapy: a pilot study. Arthritis Rheum 1991; 34: 646-54.
57. Prinz B, Michelsen S, Pfeiffer C, Plewig G. Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis. J Am Acad Dermatol 1999; 40: 577-82.
58. Reinisch W, Nahavandi H, Santella R, Zhang Y, Gasche C, Moser G, et al. Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study. Aliment Pharmacol Ther 2001; 15: 1313-22.
59. Nijsten TE, Stern RS. Genital squamous cell carcinoma in men treated by photochemotherapy: a cancer registry-based study from 1978 to 1998: Br J Dermatol 2002; 147: 184-5.
60. Gmyrek R, Beer R, Elizeri Y, Oster MW, Silvers DN, Schneiderman P, et al. Invasive squamous cell carcinoma with sporotrichoid metastasis in a patient with cutaneous T cell lymphoma treated with chronic extracorporeal photopheresis. Cutis 1999; 64: 261-4.
61. Greene MI, Sy MS, Kripke M, Benacerraf B. Impairment of antigen-presenting cell function by ultraviolet radiation. Proc Natl Acad Sci USA 1979; 76: 6591-5.
62. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107: 235-42.
63. Vowels BR, Cassin M, Boufal MH, Walsh LJ, Rook AH. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992; 98: 686-92.
64. Tokura Y, Seo N, Yagi H, Wakita H, Moriwaki S, Furukawa F, et al. Treatment of T lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production. J Invest Dermatol 1999; 113: 202-8.
65. Hanlon DJ, Berger CL, Edelson RL. Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes. Int J Cancer 1998; 78: 70-5.
66. Berger CL, Xu AL, Hanlon D, Lee C, Schechner J, Glusac E, et al. Induction of human tumor-loaded dendritic cells. Int J Cancer 2001; 91: 438-47.
67. Chaperot L, Chokri M, Jacob MC, Drillat P, Garban F, Egelhofer H, et al. Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma. Leukemia 2000; 14: 1667-77.